1. Preface

   • Hidehiko Saito
   • Makoto Ogawa
   • Yutaka Ariyoshi

   Pages: S1 - S1

2. Problems in the development of target-based drugs

   • Nagahiro Saijo
   • Tomohide Tamura
   • Kazuto Nishio

   Pages: S43 - S45

3. Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies

   • William G. Nelson
   • Jonathan W. Simons
   • Fray F. Marshall

   Pages: S67 - S72

4. Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer

   • Kerry A. Chester
   • Astrid Mayer
   • Richard H. J. Begent

   Pages: S8 - S12

5. Human CD8 and CD4 T cell epitopes of epithelial cancer antigens

   • Noriyuki Sato
   • Yuki Nabeta
   • H. Ikeda

   Pages: S86 - S90

6. Recombinant antibodies against ganglioside expressed on tumor cells

   • Nobuo Hanai
   • Kazuyasu Nakamura
   • Kenya Shitara

   Pages: S13 - S17

7. An immunotherapeutic approach to treatment of breast cancer: focus on trastuzumab plus paclitaxel

   • Teresa Gilewski
   • Andrew Seidman
   • Breast Cancer Medicine Service

   Pages: S23 - S26

8. Exploitation of the B cell repertoire for the identification of human tumor antigens

   • Michael Pfreundschuh

   Pages: S3 - S7

9. Cancer immunotherapy in clinical oncology

   • Alexander Knuth
   • Dirk Jäger
   • Elke Jäger

   Pages: S46 - S51

10. SEREX analysis of gastric cancer antigens

    • Yuichi Obata
    • Toshitada Takahashi
    • Lloyd J. Old

    Pages: S37 - S42

11. Melanoma vaccines: the paradox of T cell activation without clinical response

    • Mai-Britt Nielsen
    • Francesco M. Marincola

    Pages: S62 - S66

12. Progress reports on immune gene therapy for stage IV renal cell cancer using lethally irradiated granulocyte-macrophage colony-stimulating factor-transduced autologous renal cancer cells

    • Kenzaburo Tani
    • Yukoh Nakazaki
    • Shigetaka Asano

    Pages: S73 - S76

13. Use of major histocompatibility complex class I tetramers to monitor tumor-specific cytotoxic T lymphocyte response in melanoma patients

    • Vincenzo Cerundolo

    Pages: S83 - S85

14. Development of a cancer vaccine: peptides, proteins, and DNA

    • Hiroshi Shiku
    • Lijie Wang
    • Hideo Nakamura

    Pages: S77 - S82

15. Targeted therapy of acute myeloid leukemia with monoclonal antibodies and immunoconjugates

    • Eric L. Sievers

    Pages: S18 - S22

16. Organ-specific expression of the intestinal epithelium-related antigen A33, a cell surface target for antibody-based imaging and treatment in gastrointestinal cancer

    • Junichi Sakamoto
    • Hiroshi Kojima
    • H. Suzuki

    Pages: S27 - S32

17. Immune recruitment by bispecific antibodies for the treatment of Hodgkin disease

    • Ligia da Costa
    • Christoph Renner
    • Michael Pfreundschuh

    Pages: S33 - S36

18. The critical role of Th1-dominant immunity in tumor immunology

    • Takashi Nishimura
    • Minoru Nakui
    • Shinichiro Nishimura

    Pages: S52 - S61